Astrana Health Inc (ASTH)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 158,922 | 293,807 | 288,027 | 233,097 | 193,470 |
| Short-term investments | US$ in thousands | 2,378 | 2,498 | 5,567 | 53,417 | 67,695 |
| Total current liabilities | US$ in thousands | 222,688 | 218,674 | 148,610 | 114,719 | 114,992 |
| Cash ratio | 0.72 | 1.36 | 1.98 | 2.50 | 2.27 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($158,922K
+ $2,378K)
÷ $222,688K
= 0.72
The cash ratio of Astrana Health Inc has shown fluctuations over the years. As of December 31, 2020, the company had a cash ratio of 2.27, indicating that it had $2.27 in cash and cash equivalents for every $1 of current liabilities. This ratio increased to 2.50 by December 31, 2021, reflecting a stronger liquidity position.
However, in the following years, the cash ratio declined. By December 31, 2022, it dropped to 1.98, suggesting a slight reduction in the company's ability to cover its short-term obligations with available cash. The trend continued with a further decrease to 1.36 by December 31, 2023, signaling a potential strain on the company's liquidity.
The most significant drop in the cash ratio was observed by December 31, 2024, where the ratio fell to 0.72. This sharp decline may raise concerns about Astrana Health Inc's ability to meet its short-term liabilities solely with cash on hand.
Overall, the decreasing trend in the cash ratio over the years indicates a weakening liquidity position for Astrana Health Inc, highlighting the importance of closely monitoring the company's cash management and working capital strategies to ensure financial stability.
Peer comparison
Dec 31, 2024